Inventor
COFFEY MATTHEW C
CA64 patents
⚠️ This page may combine multiple inventors who share the name “COFFEY MATTHEW C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ONCOLYTICS BIOTECH INC
41 patentsUS7901921B2Mar 8, 2011
Viral purification methods
ONCOLYTICS BIOTECH INC70 citations98
US7223585B2May 29, 2007
Viral purification methods
ONCOLYTICS BIOTECH INC64 citations98
US6136307AOct 24, 2000
Reovirus for the treatment of cellular proliferative disorders
ONCOLYTICS BIOTECH INC139 citations98
US6110461AAug 29, 2000
Reovirus for the treatment of neoplasia
ONCOLYTICS BIOTECH INC97 citations98
US7252817B2Aug 7, 2007
Viruses for the treatment of cellular proliferative disorders
ONCOLYTICS BIOTECH INC28 citations96
US6811775B2Nov 2, 2004
Reovirus for the treatment of cellular proliferative disorders
ONCOLYTICS BIOTECH INC28 citations96
US6649157B2Nov 18, 2003
Viruses for the treatment of cellular proliferative disorders
ONCOLYTICS BIOTECH INC51 citations96
US6596268B1Jul 22, 2003
Viruses for the treatment of cellular proliferative disorders
ONCOLYTICS BIOTECH INC51 citations96
US6565831B1May 20, 2003
Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
ONCOLYTICS BIOTECH INC53 citations96
US6528305B2Mar 4, 2003
Method of producing infectious reovirus
ONCOLYTICS BIOTECH INC41 citations96
US6455038B1Sep 24, 2002
Reovirus for the treatment of cellular proliferative disorders
ONCOLYTICS BIOTECH INC39 citations96
US6344195B1Feb 5, 2002
Reovirus for the treatment of neoplasia
ONCOLYTICS BIOTECH INC57 citations96
US6261555B1Jul 17, 2001
Reovirus for the treatment of neoplasia
ONCOLYTICS BIOTECH INC53 citations96
US7964186B2Jun 21, 2011
Viruses for the treatment of cellular proliferative disorders
ONCOLYTICS BIOTECH INC8 citations93
US7803385B2Sep 28, 2010
Reoviruses having modified sequences
ONCOLYTICS BIOTECH INC24 citations93
US7708987B2May 4, 2010
Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
ONCOLYTICS BIOTECH INC14 citations93
US7608257B2Oct 27, 2009
Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus
ONCOLYTICS BIOTECH INC12 citations93
US7452723B2Nov 18, 2008
Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
ONCOLYTICS BIOTECH INC23 citations93
US7431932B2Oct 7, 2008
Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions
ONCOLYTICS BIOTECH INC15 citations93
US7306902B2Dec 11, 2007
Oncolytic viruses as phenotyping agents for neoplasms
ONCOLYTICS BIOTECH INC27 citations93
US7264798B2Sep 4, 2007
Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus
ONCOLYTICS BIOTECH INC27 citations93
US7186542B2Mar 6, 2007
Method of extracting virus from cell culture
ONCOLYTICS BIOTECH INC24 citations93
US7052832B2May 30, 2006
Methods for the treatment of cellular proliferative disorders
ONCOLYTICS BIOTECH INC22 citations93
US7049127B2May 23, 2006
Method of producing infectious reovirus
ONCOLYTICS BIOTECH INC24 citations93
US7014847B2Mar 21, 2006
Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders
ONCOLYTICS BIOTECH INC22 citations93
US6994858B2Feb 7, 2006
Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions
ONCOLYTICS BIOTECH INC25 citations93
US6808916B2Oct 26, 2004
Method of extracting virus from cell culture
ONCOLYTICS BIOTECH INC32 citations93
US7374752B2May 20, 2008
Reovirus for the treatment of cellular proliferative disorders
ONCOLYTICS BIOTECH INC10 citations92
US6576234B2Jun 10, 2003
Reovirus for the treatment of neoplasia
ONCOLYTICS BIOTECH INC24 citations92
US7964187B2Jun 21, 2011
Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus
ONCOLYTICS BIOTECH INC8 citations84
US7198783B2Apr 3, 2007
Sensitization of neoplastic cells to radiation therapy with reovirus
ONCOLYTICS BIOTECH INC11 citations84
US7815914B2Oct 19, 2010
Methods for the treatment of cellular proliferative disorders
ONCOLYTICS BIOTECH INC4 citations74
US7731951B2Jun 8, 2010
Viruses for the treatment of cellular proliferative disorders
ONCOLYTICS BIOTECH INC7 citations74
US6703232B2Mar 9, 2004
Method of producing infectious reovirus
ONCOLYTICS BIOTECH INC10 citations74
US10596260B2Mar 24, 2020
Reoviruses having modified sequences
ONCOLYTICS BIOTECH INC1 citations73
US7300650B2Nov 27, 2007
Reovirus for the treatment of neoplasia
ONCOLYTICS BIOTECH INC6 citations73
US9610352B2Apr 4, 2017
Lyophilized viral formulations
ONCOLYTICS BIOTECH INC3 citations71
US9610309B2Apr 4, 2017
Liquid viral formulations
ONCOLYTICS BIOTECH INC4 citations71
US11246930B2Feb 15, 2022
Reoviruses having modified sequences
ONCOLYTICS BIOTECH INC0 citations63
US10039827B2Aug 7, 2018
Reoviruses having modified sequences
ONCOLYTICS BIOTECH INC1 citations63
US7799329B2Sep 21, 2010
Viruses for the treatment of cellular proliferative disorders
ONCOLYTICS BIOTECH INC2 citations63
COFFEY MATTHEW C
6 patentsUS8685734B2Apr 1, 2014
Viral purification methods
COFFEY MATTHEW C53 citations98
US9045728B2Jun 2, 2015
Liquid viral formulations
COFFEY MATTHEW C10 citations82
US8470312B2Jun 25, 2013
Abrogating proinflammatory cytokine production during oncolytic reovirus therapy
COFFEY MATTHEW C7 citations81
US9044498B2Jun 2, 2015
Lyophilized viral formulations
COFFEY MATTHEW C4 citations71
US8691241B2Apr 8, 2014
Reoviruses having modified sequences
COFFEY MATTHEW C3 citations63
US8298785B2Oct 30, 2012
Use of ribozymes in the detection of adventitious agents
COFFEY MATTHEW C2 citations63
LEE PATRICK W K
2 patentsTHOMPSON BRADLEY G
1 patentShowing the top 50 of 64 patents by PatentIndex Score.